ABPI launches updated Code of Practice
The new Code has been updated to reflect changes in the pharma environment
Read More
Tag: code of practice
ABPI consults on ‘new-look’ Code of Practice
A new version of the Code is expected to come into force in July 2021
Read More
PIPA releases patient enquiries guidance
The guidance was formed after PIPA found that information provided in response to patient enquiries varied significantly between companies.
Read More
ABPI publishes new guidelines on pharma working with patients
The sourcebook covers six topics, which were identified as areas where further guidance would be of assistance.
Read More
Four pharmas named for breaching ABPI Code of Practice
Martindale Pharma, Pierre Fabre, Janssen and Pharmasure have all been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s Code of Practice.
Read More
UCB and PharmaMar breach ABPI Code of Practice
UCB and PharmaMar have been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s Code of Practice.
Read More
Pharma companies fall foul of ABPI’s Code of Practice
Sunovion Pharmaceuticals Europe, Bayer, Astellas UK, Astellas Europe and Menarini Pharma UK SRL have been named in adverts for breaching of the ABPI’s Code of Practice.
Read More
Pharma companies fall foul of ABPI’s Code of Practice
Sunovion Pharmaceuticals Europe, Bayer, Astellas UK, Astellas Europe and Menarini Pharma UK SRL have been named in adverts for breaching of the ABPI’s Code of Practice.
Read More
2016 saw jump in complaints to UK pharma regulator
The number of complaints to the Prescription Medicines Code of Practice Authority, which polices adherence to the Association of the British Pharmaceutical Industry’s Code of Practice, jumped significantly last year.
Read More
Astellas and Gedeon named for ABPI Code breaches
Astellas UK and Gedeon Richter (UK) have been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s Code of Practice.
Read More
Five pharmas fall foul of ABPI Code of Practice
A stream of breaches of the Association of the British Pharmaceutical Industry’s Code of Practice has seen five pharmaceutical companies – AstraZeneca, Gruenenthal, Janssen-Cilag, Boehringer Ingelheim and Eli Lilly – named and shamed in the British medical press.
Read More
AstraZeneca, Genzyme named for ABPI code breaches
AstraZeneca and Genzyme have been named and shamed in advertisements for separate breaches of the Association of the British Pharmaceutical Industry’s Code of Practice.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
